Production (Stage)
Generation Bio Co.
GBIO
$0.3706
-$0.0124-3.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 114.91% | 45.52% | 252.00% | 364.89% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 114.91% | 45.52% | 252.00% | 364.89% | -- |
| Cost of Revenue | 8.72% | -43.44% | -35.65% | -29.46% | -42.04% |
| Gross Profit | 55.18% | 57.13% | 73.57% | 49.38% | 63.82% |
| SG&A Expenses | -10.85% | -37.51% | -17.67% | -21.85% | -13.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.31% | -40.60% | -27.56% | -25.85% | -28.98% |
| Operating Income | 25.29% | 47.05% | 46.69% | 35.99% | 40.62% |
| Income Before Tax | 80.14% | 39.23% | 45.83% | 34.23% | -132.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 80.14% | 39.23% | 45.83% | 34.23% | -132.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 80.14% | 39.23% | 45.83% | 34.23% | -132.26% |
| EBIT | 25.29% | 47.05% | 46.69% | 35.99% | 40.62% |
| EBITDA | 26.09% | 48.33% | 48.33% | 37.28% | 42.18% |
| EPS Basic | 80.31% | 39.90% | 46.51% | 35.10% | -110.55% |
| Normalized Basic EPS | 23.05% | 48.96% | 50.56% | 40.18% | 50.24% |
| EPS Diluted | 80.31% | 39.90% | 46.51% | 35.10% | -110.55% |
| Normalized Diluted EPS | 23.05% | 48.96% | 50.56% | 40.18% | 50.24% |
| Average Basic Shares Outstanding | 0.86% | 1.10% | 1.26% | 1.33% | 10.30% |
| Average Diluted Shares Outstanding | 0.86% | 1.10% | 1.26% | 1.33% | 10.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |